Introduction
Autosomal Dominant Polycystic Kidney Disease (ADPKD) has an incidence of 1 in 1000 in Caucasians. The formation of a large number of fluid-filled cysts in both kidneys together with interstitial fibrosis usually causes chronic renal failure in 50% of patients by the age of 60 years. Frequently occurring extra-renal manifestations are hypertension, cysts in liver and pancreas, and the occurrence of cerebral aneurysms. In 85% of ADPKD-families the disease is caused by a mutation in the PKD1-gene. 1 These patients have a more severe progression of the disease compared to patients with a mutation in the PKD2-gene.
2
A large part of the PKD1-gene is reiterated at another locus on chromosome 16p, hampering mutation detection using straightforward techniques. 3 The unique 3' part of the gene, exons 34 ± 46, harbours only 10% of the mutations. 4 Basically, the strategy to screen the reiterated part of the gene is to use long-range PCR with primers in unique parts of the gene, followed by nested PCR reactions to amplify the different exons. 5, 6 We describe here the screening of exons 2 ± 10 by DGGE in 12 overlapping fragments.
Methods

Patients
In this study we analysed DNA from 36 individuals diagnosed as having ADPKD, 25 linked to the PKD1-gene on chromosome 16, other families are too small to establish linkage. The majority of patients have been analysed for most of exons 15 and 23 ± 46.
PCR amplification of DNA LR ± PCR was performed, in 50 ml reactions, using the EXPAND TM PCR system (Roche, Mannheim, Germany) with buffer system 3 containing: 2.25 mM MgCl 2 , 50 mM of each dNTP, 300 nM of each primer (pPKDin1AF and pTr) and 250 ng genomic DNA. Samples were amplified in 0.2 ml thin-walled tubes using a Perkin Elmer DNA thermocycler (Geneamp PCRsys 2400, PE Applied Biosystems, Nieuwerkerk a/d/ IJssel, The Netherlands). The PCR programme recommended by the manufacturer was used with denaturing, annealing and elongation temperatures of 94, 66, and 688C respectively and elongation times of 10 min increasing with 20 s per cycle.
Nested PCR's for exons 2 ± 10 were performed on the 6.8 kb pPKDin1aF-pTr products isolated from gel using low meltingpoint (LMP) agarose. Samples were always loaded with empty lanes in between. Nested PCR's were performed on 10 5 times diluted products with intronic primers to amplify all exons and adjacent splice and branch sites. Primers were selected using the melt map programme WINMELT version 2.0. For each fragment a 50 or 55 bp GC-clamp was attached at the 5' or 3' end of one of the primers. A single set of primers was used for each exon except for exons 5 and 10 where two and three pairs were needed respectively ( Table 1) .
Denaturing gradient gel electrophoresis (DGGE)
Amplified fragments were analysed on a 9% polyacrylamide gel (37.5 : 1; Mallinckrodt-Baker, Deventer, The Netherlands) with linear denaturing gradients of 40 to 100% of a mixture of 40% formamide (Mallinckrodt-Baker) and 7 M urea (USB, Amersham Pharmacia Biotech, Roosendaal, The Netherlands), for details see Table 1 . Electrophoresis was performed at a constant temperature of usually 588C, at 100 V for 8 ± 16 h.
Results
Alignment of the PKD1 genomic sequence and the sequence of a Bacterial Artificial Chromosome (BAC) clone that contains two copies of the homologous loci (Genbank AC002039), was previously shown to reveal regions in the PKD1-gene that were not duplicated in the two homologous genes. 7 In one of these regions in intron 1, close to exon 2, we selected a PCR primer for long-range PCR (pPKDin1AF). The other primer (pTr) is located in exon 11. To validate specificity of the amplified products radiation hybrid HJ145.19, which contains only the PKD1-gene and the rodent-human somatic cell hybrid N23HA, which contains only the homologous region, were used as controls. 3 Longrange PCR revealed in human DNA a 6.8 kb band that was also present in HJ145.19 but absent in N23HA (Figure 1 ). In addition a 1.2 kb band was observed sometimes in N23HA, although with varying intensities. This band was always absent in HJ145.19, indicating that it may be a product of one of the copies of the PKD1 gene at a proximal location on chromosome 16 (Figure 1 ). We therefore always isolated the 6.8 kb band from a low melting point agarose gel, and nested PCR's were performed on a 10 5 dilution of this product.
Nested PCR's never revealed products on the 6.8 kb region isolated from gel in the N23HA control somatic cell hybrid (not shown).
Denaturing gradient gel electrophoresis for PKD1 exons 2 to 10 For DGGE-analysis gene-specific fragments of 119 ± 372 bp were generated. A single set of primers was used for each exon GGG GAG GTG GAG TTC TCG GTT TGC C pTr CCT CCA AGT AGT TGC GCT GTG ATC G a 1 50 gc-clamp (5' ± 3'): CGCCCGCCGCGCCCCGCGCCCGGCCCGCCGCCCCCGCCCGCGCCCCCGGC. DGGE analysis for exons 2 to 10 of the PKD1-gene DJM Peters et al 958 except for exons 5 and 10 where two and three pairs were needed respectively. A total of 11 different sequence variants were observed ( Table 2 ) that were confirmed on fresh LR ± PCR's followed by nested PCR's on DNA of the patients and/ or additional family members.
Truncating mutations Analysis of exon 5 (fragment 5C) revealed a nonsense mutation in family PK4. This mutation, R400X predicts a translation stop at amino acid 400 and generates a DdeI restriction site. The index patient of this family died at 68 years of age from cardiac infarction. Polycystic kidneys were an unexpected finding at autopsy. In total 15 affected family members were collected, two of them reached end stage renal failure (ESRF) before 50 years.
Analysis of exon 8 revealed a frame shift mutation in family PK10. Deletion of a C in a stretch of 4C's at position 1703 ± 1706, predicts a frame shift at amino acid 596 resulting in a truncated protein of 610 amino acids. The index patient was a male, with polycystic kidney and liver disease, who entered into renal failure at 69 years and died at the age of 72 due to heart failure. He had six children with polycystic kidney disease. One of them entered into renal failure at the age of 31.
Coding and non-coding polymorphisms Two amino acid substitutions were identified: 276G4A in exon 2, resulting in the amino acid substitution A92T 4 was once identified.
1919C4T, in the overlap of fragments ex10A and ex10B, results in the substitution A637V and was identified in four families including family 10 for which we identified a frame shift mutation in exon 8 (see above). Analysis of exon 5 revealed two silent mutations 1023C4A (A341A) and 1120T4A (L373L) both also described by Rosetti et al. 4 Five intronic polymorphisms in introns 1 (216779C4T), 7 (1620739C4T), 8 (1722+23C4T and 1723727G4A) and 9 (185074G4T) were observed with varying frequencies.
Discussion
We have performed mutation detection for the PKD1-gene to gain insight into the mutation spectrum but also for diagnostic applications in ADPKD patients. Sequencing the entire 14 kilobases of coding DNA of the PKD1 gene is a daunting task. We therefore prefer to pre-screen fragments of the gene searching for variants. We have chosen to screen the PKD1-gene by DGGE because the sensitivity to detect sequence variants can reach to a value close to 100% when a GC-clamp is introduced in the fragment during PCR. 8 Exons 2 ± 10 comprise approximately 1.7 kb (13%) of coding sequence in which we identified two (5%) truncating mutations in 36 patients and several variants were identified which are likely to be non-disease causing polymorphisms. These data are in a similar range as observed by Rosetti et al. 4 who screened the same region of the gene by direct sequencing. However, Phakdeekitharoen et al. 9 did not find any mutation in this part of the gene by heteroduplex analysis in 40 Thai families. DGGE-analysis for other parts of the gene have been reported previously. 10, 11 All the available data suggest that with a few exceptions 4 each family with ADPKD has its own`private' mutation. The mutation detection rate for the gene as a whole is around 60% 
